The goal of this study was to define the role of the classical complement activation pathway in the progression of pathology in the 3xTg mouse that develops tangles in addition to fibrillar plaques ( more closely reflecting human AD pathology ) and to assess the influence of complement in a model of AD with a higher level of complement hemolytic activity.